|Bid||4.75 x 300|
|Ask||9.20 x 300|
|Day's Range||7.25 - 7.56|
|52 Week Range||3.96 - 14.00|
|PE Ratio (TTM)||-0.74|
|Earnings Date||Aug 1, 2017 - Aug 7, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||12.00|
BERKELEY, Calif., May 18, 2017-- XOMA Corporation, a pioneer in the discovery and development of therapeutic antibodies, today announced it has earned a $10 million milestone payment, reflecting the clinical ...
BERKELEY, Calif., May 15, 2017-- XOMA Corporation, a pioneer in the discovery and development of therapeutic antibodies, announced today that Jim Neal, Chief Executive Officer, will present the Company’ ...
The Berkeley, California-based company said it had a loss of $2.37 per share. Losses, adjusted to extinguish debt, were $2.30 per share. The drug developer posted revenue of $260,000 in the period. Xoma ...